Immune Cytolysis of Human Tumor Cells Mediated by Xenogeneic "Immune" RNA
- 1 July 1974
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 109 (1) , 30-34
- https://doi.org/10.1001/archsurg.1974.01360010022004
Abstract
Using a quantitative assay for lymphocyte-mediated cytotoxicity, it was shown that normal nonimmune human lymphocytes were converted to effector cells specifically cytotoxic to human tumor cells in vitro by incubation with "immune" RNA extracted from the lymphoid organs of specifically immunized guinea pigs or sheep. Lymphocytes incubated without RNA or with control RNA preparations failed to show cytotoxic activity. These immune responses were abrogated when the immune RNA was treated with RNAase prior to incubation with lymphocytes. However, treatment with DNAase or pronase did not alter the activity of the immune RNA.This publication has 8 references indexed in Scilit:
- INDUCTION OF ANTI‐CANCER IMMUNITY WITH RNAAnnals of the New York Academy of Sciences, 1973
- Monkey to human transfer of delayed hypersensitivity in vitro with RNA extractsCellular Immunology, 1972
- RNA-mediated transfer of tumor immunity —A new model for the immunotherapy of cancerCancer, 1971
- Transfer of tumor immunity with ribonucleic acidCancer, 1970
- Mediation of Immunity to Tumor Isografts in Mice by Heterologous Ribonucleic AcidScience, 1970
- Acceleration of Allograft Rejection Induced by RNA from Sensitized DonorsInternational Archives of Allergy and Immunology, 1967
- Transfer of Heightened Immunity to Skin Homografts by Lymphoid RNA *Journal of Clinical Investigation, 1964
- ANTIBODY FORMATION IN VITROThe Journal of Experimental Medicine, 1961